| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
phenotype | 0.400 | None | 1.000 | 339 | 5 | 1997 | 2020 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
phenotype | 0.400 | None | 1.000 | 91 | 5 | 2009 | 2020 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
phenotype | 0.400 | None | 1.000 | 21 | 4 | 1996 | 2019 | ||||||||
|
S100 calcium binding protein A10 | 0.528 | 0.769 | 0.17 |
|
phenotype | 0.400 | None | 1.000 | 16 | 0 | 2006 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.400 | None | 1.000 | 10 | 0 | 2007 | 2019 | ||||||||
|
arginine vasopressin | 0.437 | 0.846 | 7.4E-02 |
|
phenotype | 0.400 | None | 1.000 | 10 | 0 | 2001 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 4 subunit | 0.492 | 0.808 | 8.5E-05 |
|
phenotype | 0.340 | None | 1.000 | 4 | 2 | 2008 | 2019 | ||||||||
|
calcitonin related polypeptide alpha | 0.416 | 0.923 | 1.6E-02 |
|
phenotype | 0.330 | None | 1.000 | 3 | 0 | 2006 | 2018 | ||||||||
|
MYD88 innate immune signal transduction adaptor | 0.414 | 0.923 | 0.12 |
|
phenotype | 0.320 | None | 1.000 | 2 | 0 | 2014 | 2015 | ||||||||
|
tripartite motif containing 69 | 0.612 | 0.731 | 2.6E-09 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
orosomucoid 1 | 0.608 | 0.731 | 1.1E-05 |
|
phenotype | 0.310 | None | 0.500 | 1 | 0 | 1988 | 2003 | ||||||||
|
pentraxin 3 | 0.457 | 0.808 | 7.0E-05 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
kynurenine aminotransferase 1 | 0.736 | 0.308 | 1.9E-12 |
|
phenotype | 0.310 | None | 0.500 | 1 | 1 | 2012 | 2018 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.100 | None | 0.960 | 403 | 9 | 2003 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.100 | None | 0.935 | 108 | 1 | 1995 | 2020 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.100 | None | 0.904 | 104 | 0 | 1996 | 2019 | ||||||||
|
cat eye syndrome chromosome region | 0.599 | 0.731 |
|
phenotype | 0.100 | None | 0.989 | 88 | 0 | 1994 | 2020 | |||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.100 | None | 0.962 | 78 | 1 | 2002 | 2020 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
phenotype | 0.100 | None | 0.970 | 66 | 3 | 1999 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
phenotype | 0.100 | None | 0.984 | 61 | 1 | 1999 | 2020 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
phenotype | 0.100 | None | 0.904 | 52 | 7 | 1983 | 2019 | ||||||||
|
FKBP prolyl isomerase 5 | 0.524 | 0.769 | 0.73 |
|
phenotype | 0.100 | None | 0.941 | 51 | 4 | 2007 | 2019 | ||||||||
|
progestagen associated endometrial protein | 0.430 | 0.846 | 3.1E-08 |
|
phenotype | 0.100 | None | 0.957 | 47 | 0 | 2009 | 2020 | ||||||||
|
activating transcription factor 7 interacting protein | 0.543 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0.978 | 46 | 0 | 1996 | 2020 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
phenotype | 0.100 | None | 1.000 | 44 | 0 | 1992 | 2019 |